(3H)-Propranolol binding sites in myocardial membranes: nonidentity with beta adrenergic receptors.
D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D002078:Butoxamine / Q000494:pharmacology; D002395:Catecholamines / Q000037:antagonists & inhibitors; D002746:Chlorpromazine / Q000494:pharmacology; D004285:Dogs; D004789:Enzyme Activation; D006220:Haloperidol / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008566:Membranes / Q000378:metabolism; D009206:Myocardium / Q000166:cytology* / Q000201:enzymology; D009756:Nylidrin / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010761:Phosphorus Radioisotopes; D011433:Propranolol / Q000378:metabolism*; D011941:Receptors, Adrenergic / Q000187:drug effects*; D013015:Sotalol / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013997:Time Factors; D014316:Tritium
D000067956:Adenylyl Cyclase Inhibitors; D002395:Catecholamines; D010277:Parasympathomimetics; D010761:Phosphorus Radioisotopes; D011941:Receptors, Adrenergic; D002078:Butoxamine; D014316:Tritium; D009756:Nylidrin; D011433:Propranolol; D013015:Sotalol; D000262:Adenylyl Cyclases; D006220:Haloperidol; D007545:Isoproterenol; D002746:Chlorpromazine; D010646:Phentolamine